Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00512031 · ClinicalTrials.gov registry record
Characterizing PAI-1 Modulation on Monocyte Adhesion
A clinical trial, sponsored by Vanderbilt University.
- Terminated
- Registry status
- 50
- Enrollment target
NCT00512031: Clinical Trial study, sponsored by Vanderbilt University.
NCT00512031 is a clinical trial that was terminated before completion, run by Vanderbilt University. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00512031 was terminated before completion, sponsored by Vanderbilt University.
- TERMINATED
- Registry status
- 50 participants
- Enrollment target
Study Summary
To determine how altering the expression of a gene known as PAI-1 may affect the adhesive capacity of cells that play a critical role in the developement of human atherosclerosis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2007-01 |
| Est. Completion | 2011-07 |
Why NCT00512031 stopped before completion
NCT00512031 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00512031 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00512031 about?
NCT00512031 is a clinical study titled "Characterizing PAI-1 Modulation on Monocyte Adhesion". To determine how altering the expression of a gene known as PAI-1 may affect the adhesive capacity of cells that play a critical role in the developement of human atherosclerosis.
What is the current status of trial NCT00512031?
This trial is currently terminated. The enrollment target is 50 participants. The study started on 2007-01. Estimated completion is 2011-07.
Who is sponsoring clinical trial NCT00512031?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia